Safety and Effectiveness of Vedolizumab IV in Real World Clinical Practice in Taiwan: A Registry-Based Study

31/01/2019
25/03/2024
EU PAS number:
EUPAS27544
Study
Finalised
Documents
Study protocol
Initial protocol
English (1.67 MB - PDF) View document
Study results
Study results
English (940.7 KB - PDF) View document
Study report
Other information